Skip to content
Baret News – Lifestyle
Author:
ALTRUIST BIOLOGICS
Altruist Biologics’ Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production
July 8, 2026
Altruist Biologics’ Hangzhou Facility Secures First Commercial Manufacturing License
April 8, 2026
Altruist Biologics Launches Altru-CON™ High-Concentration Formulation Platform to Accelerate Biologics Development
March 4, 2026